Companion diagnostics have revolutionized the field of precision oncology by enabling the identification of patients who will benefit most from targeted therapies. Focusing on the genetic and molecular characteristics of an individual's cancer, these diagnostics have significantly improved
The development of a new blood test designed to diagnose and monitor the progression of Alzheimer’s disease is a leap forward in medical science. Researchers from Washington University and Lund University have spearheaded this innovation. Unlike existing tests, which lack the capacity to reveal the
The Llantrisant Health Park near the Royal Glamorgan Hospital is poised for a transformational role as a regional diagnostic and treatment center for patients in South East Wales. It will serve areas including Gwent, Cardiff, the Vale of Glamorgan, and the Glamorgan Valleys. Health officials are
Singapore is pioneering an innovative approach to Covid-19 research through human challenge studies, where volunteers are deliberately infected with the virus in controlled settings. This approach contrasts with traditional methods where infections occur naturally, allowing researchers to obtain
Agilent Technologies has made a significant leap forward with the receipt of EU In Vitro Diagnostic Regulation (IVDR) certification for its PD-L1 IHC 28-8 pharmDx kit as a companion diagnostic for non-small cell lung cancer (NSCLC) and melanoma. This certification broadens the indications for the
Blood tests have come a long way since the 19th century, evolving into essential tools for diagnosing and monitoring various health conditions, including cancer. In breast cancer care, blood tests play a crucial role, providing valuable insights that complement other diagnostic methods. The Role of
